According to Daito Pharmaceutical latest financial reports the cash on hand of 4577 is $25.28M, an decrease of -17.67% to 2022. At the end of 2022 company had $30.71M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $25.28M | -17.67% |
2022 | $30.71M | 29.92% |
2021 | $23.64M | 9.33% |
2020 | $21.62M | 69.51% |
2019 | $12.75M | - |